BEHNAZ HAGHIGHI MOTLAGH: Open Payments
NPI 1902125776 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 44 payments from 16 companies in 2025. Trend: 2023 $885 · 2024 $772 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $214 |
| AstraZeneca Pharmaceuticals LP | 3 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $129 |
| Novo Nordisk Inc | 4 | $99 |
| Kowa Pharmaceuticals America, Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $73 |
| Exact Sciences Corporation | 3 | $68 |
| Amgen Inc. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Indivior Inc. | 2 | $50 |
Products named: VRAYLAR, FARXIGA, Kerendia, ZORYVE, Ozempic, MOUNJARO, LINZESS, GEMTESA.
Industry payments across CA — which companies pay providers there.
